These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11168087)

  • 1. Eradication of a resistant Pseudomonas aeruginosa strain after a cluster of infections in a hematology/oncology unit.
    Gillespie TA; Johnson PR; Notman AW; Coia JE; Hanson MF
    Clin Microbiol Infect; 2000 Mar; 6(3):125-30. PubMed ID: 11168087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of piperacillin/tazobactam against 615 Pseudomonas aeruginosa strains isolated in intensive care units.
    Bonfiglio G; Laksai Y; Franceschini N; Perilli M; Segatore B; Bianchi C; Stefani S; Amicosante G; Nicoletti G
    Chemotherapy; 1998; 44(5):305-12. PubMed ID: 9732144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance patterns of Pseudomonas aeruginosa to carbapenems and piperacillin/tazobactam.
    Mokaddas EM; Sanyal SC
    J Chemother; 1999 Apr; 11(2):93-6. PubMed ID: 10326738
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Goodlet KJ; Nicolau DP; Nailor MD
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections.
    Onguru P; Erbay A; Bodur H; Baran G; Akinci E; Balaban N; Cevik MA
    J Korean Med Sci; 2008 Dec; 23(6):982-7. PubMed ID: 19119440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15).
    Pfaller MA; Bassetti M; Duncan LR; Castanheira M
    J Antimicrob Chemother; 2017 May; 72(5):1386-1395. PubMed ID: 28165526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-2011.
    Haeili M; Ghodousi A; Nomanpour B; Omrani M; Feizabadi MM
    J Infect Dev Ctries; 2013 Apr; 7(4):312-7. PubMed ID: 23592640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The frequency of PER-1 type extended spectrum beta-lactamases in nosocomial isolates of Pseudomonas aeruginosa].
    Zarakolu P; Metan G; Gürkan Aydin N; Altun B; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Jul; 41(3):363-7. PubMed ID: 17933246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of Pseudomonas aeruginosa in intensive care units: clusters of nosocomial cross-infection and encounter of a multiple-antibiotic resistant strain.
    Traub WH; Scheidhauer R; Leonhard B; Bauer D
    Chemotherapy; 1998; 44(4):243-59. PubMed ID: 9681201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015).
    Pfaller MA; Shortridge D; Sader HS; Castanheira M; Flamm RK
    Int J Antimicrob Agents; 2018 Feb; 51(2):181-189. PubMed ID: 28993143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit.
    Sader HS; Pignatari AC; Leme IL; Burattini MN; Tancresi R; Hollis RJ; Jones RN
    Diagn Microbiol Infect Dis; 1993 Jul; 17(1):13-8. PubMed ID: 8359000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal multi-resistant Pseudomonas aeruginosa septicemia outbreak in a neonatal intensive care unit in Trinidad.
    Orrett FA
    Ethiop Med J; 2000 Apr; 38(2):85-91. PubMed ID: 11144887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and resistance characteristics of Pseudomonas aeruginosa isolates from the respiratory department of a hospital in China.
    Feng W; Sun F; Wang Q; Xiong W; Qiu X; Dai X; Xia P
    J Glob Antimicrob Resist; 2017 Mar; 8():142-147. PubMed ID: 28216097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiresistant Pseudomonas aeruginosa outbreak in a pediatric oncology ward related to bath toys.
    Buttery JP; Alabaster SJ; Heine RG; Scott SM; Crutchfield RA; Bigham A; Tabrizi SN; Garland SM
    Pediatr Infect Dis J; 1998 Jun; 17(6):509-13. PubMed ID: 9655544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients.
    Harris AD; Perencevich E; Roghmann MC; Morris G; Kaye KS; Johnson JA
    Antimicrob Agents Chemother; 2002 Mar; 46(3):854-8. PubMed ID: 11850272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of outbreaks and containment of drug-resistant Pseudomonas aeruginosa in a Tokyo hospital.
    Sekiguchi J; Teruya K; Horii K; Kuroda E; Konosaki H; Mizuguchi Y; Araake M; Kawana A; Yoshikura H; Kuratsuji T; Miyazaki H; Kirikae T
    J Infect Chemother; 2007 Dec; 13(6):418-22. PubMed ID: 18095093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients.
    Adachi JA; Perego C; Graviss L; Dvorak T; Hachem R; Chemaly RF; Raad II
    Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.